SpassageQ— 510(k) K230386

Substantially Equivalent

Spass, Inc.

FDA 510(k) clearance K230386 for SpassageQ, Substantially Equivalent on 2023-06-15. Applicant: Spass, Inc..

Clearance details

Applicant: Spass, Inc.
Product code: Code PLB
Advisory panel: Cardiovascular
Date received: 2023-02-14
Decision date: 2023-06-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Seoul, KR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.